News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
Union minister of state for AYUSH Shripad Y Naik on Thursday said that the AYUSH Ministry and the Council of Scientific and Industrial Research (CSIR) will begin clinical trials of four Ayurvedic formulations on COVID-19 patients within a week.
Jubilant Generics Ltd, a subsidiary of Jubilant Life Sciences Ltd, has entered into a non-exclusive licencing agreement with US-based Gilead Sciences Inc to manufacture and sell the potential COVID-19 drug remdesivir in 127 countries, including India.
Benefits of Virabhadrasana 1 are that it stretches the stomach, chest, shoulders, and neck. It strengthens arms and back muscles, along with thighs, calves, and ankles.
CSIR’s constituent lab, Institute of Genomics and Integrative Biology (CSIR-IGIB) and TATA Sons signed a MoU for licensing of KNOWHOW for FNCAS9 Editor Linked Uniform Detection Assay (FELUDA) for rapid diagnosis of COVID-19.
Amid lockdown many Pradhan Mantri Bharatiya Janaushadhi Kendras(PMBJK) under the Union Ministry of Chemicals and Fertilizers are accepting the orders for medicines on WhatsApp and e-mail, where on the basis of uploaded prescriptions medicines are delivered at the doorsteps of the patients.
An ayurvedic drug in India called ZingiVir-H has gotten the rubber stamp to conduct clinical trials on adults who have tested positive for coronavirus in India.
Technologists at the Sree Chitra Triunal Institute for Medical Sciences and Technology (SCTIMST), an autonomous institute under the Department of Science and Technology, Govt of India, have developed two types of nasal and oral swabs and viral transport medium for COVID-19 testing.
Garudasana has many benefits. It strengthens the hips, thighs, shoulders, calves, and upper back. It improves balance and helps alleviate sciatica and rheumatism.
CSIR has been leading the fight against Covid19 epidemic on multiple fronts, with major emphasis on repurposed drugs as they can be quickly deployed for treatment as opposed to new drugs which need almost a decade of development. Globally many drugs are under clinical trials on Coronavirus patients to establish their efficacy against Covid19.
Shiv Nadar University in Greater Noida on Monday announced that its researchers have created a molecule that has the potential to be developed into a drug that can cure Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients.
